Prevention of muscle fibrosis and myonecrosis in mdx mice by suramin, a TGF-β1 blocker. (Q54630553)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21108244%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

title

Prevention of muscle fibrosis and myonecrosis in mdx mice by suramin, a TGF-β1 blocker (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21108244%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21108244%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Cintia Yuri Matsumura

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21108244%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

author name string

Ana Paula Tiemi Taniguti

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21108244%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Humberto Santo Neto

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21108244%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Maria Julia Marques

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21108244%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

publication date

1 January 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21108244%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21108244%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

43

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21108244%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21108244%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

82-87

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21108244%20AND%20SRC:MED&resulttype=core&format=json

Dystrophin: the protein product of the Duchenne muscular dystrophy locus

17 January 2020

cites work

1 reference

Cellular and molecular regulation of muscle regeneration

21 January 2018

1 reference

Targeted exon skipping as a potential gene correction therapy for Duchenne muscular dystrophy.

21 January 2018

1 reference

In vivo comparison of 2'-O-methyl phosphorothioate and morpholino antisense oligonucleotides for Duchenne muscular dystrophy exon skipping

21 January 2018

1 reference

Connective tissue growth factor is overexpressed in muscles of human muscular dystrophy

21 January 2018

1 reference

Impact of prednisone on TGF-beta1 and collagen in diaphragm muscle from mdx mice

21 January 2018

1 reference

Localization and early time course of TGF-beta 1 mRNA expression in dystrophic muscle

21 January 2018

1 reference

Temporal and spatial mRNA expression patterns of TGF-beta1, 2, 3 and TbetaRI, II, III in skeletal muscles of mdx mice.

21 January 2018

1 reference

Antifibrotic effects of suramin in injured skeletal muscle after laceration

21 January 2018

1 reference

The use of suramin, an antifibrotic agent, to improve muscle recovery after strain injury

21 January 2018

1 reference

Improved muscle healing after contusion injury by the inhibitory effect of suramin on myostatin, a negative regulator of muscle growth

21 January 2018

1 reference

Suramin in advanced platinum-resistant ovarian cancer

21 January 2018

1 reference

Suramin inhibits wound healing following filtering procedures for glaucoma

21 January 2018

1 reference

Role of tumour necrosis factor alpha, but not of cyclo-oxygenase-2-derived eicosanoids, on functional and morphological indices of dystrophic progression in mdx mice: a pharmacological approach.

21 January 2018

1 reference

The effect of suramin on bleomycin-induced lung injury

21 January 2018

1 reference

Towards developing standard operating procedures for pre-clinical testing in the mdx mouse model of Duchenne muscular dystrophy

21 January 2018

1 reference

Visualization of dystrophic muscle fibers in mdx mouse by vital staining with Evans blue: evidence of apoptosis in dystrophin-deficient muscle.

21 January 2018

1 reference

Alterations in the permeability of dystrophic fibers during neuromuscular junction development.

21 January 2018

1 reference

Suramin, a novel antitumor compound.

21 January 2018

1 reference

Suramin: clinical uses and structure-activity relationships.

21 January 2018

1 reference

Suppression of myocardial inflammation using suramin, a growth factor blocker

21 January 2018

1 reference

Enhanced Na+/H+ exchange activity contributes to the pathogenesis of muscular dystrophy via involvement of P2 receptors

21 January 2018

1 reference

Suramin is a slowly-equilibrating but competitive antagonist at P2x-receptors in the rabbit isolated ear artery

21 January 2018

1 reference

Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease

21 January 2018

1 reference

Prevention of muscle fibrosis and improvement in muscle performance in the mdx mouse by halofuginone

21 January 2018

1 reference

The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/MUS.21869

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21108244%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference